Catalyst Wire Dossier Catalyst Wire Dossier

Padsevonil

padsevonil · UCB Biopharma S.P.R.L.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Padsevonil, covering 2020-06-04 to 2021-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy [Phase 2]

See pricing